Therapy of systemic lupus erythematosus: new agents and new evidence

Author： Ruiz-Irastorza G. Khamashta M.A. Hughes G.R.

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.7, 2000-07, pp. : 1581-1593

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New therapies for the treatment of systemic lupus erythematosus

By Gullick Dr Nicola D’Cruz Dr David

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 3, 2007-03 ,pp. : 299-313

Informa Healthcare

Access to resources Recommend Favorite

Gene Therapy in Systemic Lupus Erythematosus

Current Gene Therapy, Vol. 5, Iss. 6, 2005-12 ,pp. : 677-684

Bentham Science Publishers

Access to resources Recommend Favorite

Abetimus sodium: a new therapy for delaying the time to, and reducing the incidence of, renal flare and/or major systemic lupus erythematosus flares in patients with systemic lupus erythematosus who have a history of renal disease

By Cardiel Mario H

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 1, 2005-01 ,pp. : 77-88

Informa Healthcare

Access to resources Recommend Favorite

Uncovering the Genetics of Systemic Lupus Erythematosus: Implications for Therapy

By Kyttaris V.C. Tsokos G.C.

American Journal of PharmacoGenomics, Vol. 3, Iss. 3, 2003-01 ,pp. : 193-202

Adis International

Access to resources Recommend Favorite

B-Cell-Targeted Therapy for Systemic Lupus Erythematosus

By Sabahi Ramin Anolik Jennifer H.

Drugs, Vol. 66, Iss. 15, 2006-01 ,pp. : 1933-1948

Adis International

Access to resources Recommend Favorite